Clinical trial
Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome
NCT00162981 is registered in ClinicalTrials.gov with Lundbeck LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome
- Lead sponsor
- Lundbeck LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- October 31, 2006
- Enrollment
- 68 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.